Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New Initiative Launched to Improve Care for People With Certain Types of Heart Failure

The IMPLEMENT-EF quality improvement initiative will aim to address those challenges by mapping gaps in the patient journey to identify unmet needs and define ideal care models.

The percentage of blood that leaves the left ventricle with each heartbeat is measured by ejection fraction (EF). A normal EF is between 55% and 70%. HFpEF means an individual has heart failure but EF remains 50% or higher - the heart muscle contracts, but the left ventricle does not relax as it should during ventricular filling. HFmrEF means EF is reduced to 41%-49%.

Treatment for HFpEF and HFmrEF requires earlier recognition and prompt initiation of scientific evidence-based therapies to improve health outcomes.

This new three-year initiative, supported by Bayer, will engage a network of multidisciplinary care teams - including pharmacists - to ensure people are receiving and taking the appropriate medications, raise provider awareness of best care practices and improve adherence to scientific evidence-based therapies using insights from Get With The Guidelines® - Heart Failure data. Findings will inform the American Heart Association’s broader approach to patient care and help scale effective, replicable models nationwide.

To enhance clinical understanding and encourage best practices, the initiative will include a variety of professional educational offerings, such as a podcast series, eLearning module and live presentations. The Association will convene a Science Advisory Panel to guide development of these educational materials.

“Improving care for people experiencing heart failure with preserved or mildly reduced ejection fraction requires more than just clinical knowledge. It demands a coordinated, team-based approach,” said Mariell Jessup, M.D., FAHA, chief science and medical officer of the American Heart Association. “By bringing together diverse care teams and leveraging real-world data, this initiative will help elevate the standard of care and ultimately improve outcomes for millions of people living with heart failure.”

The Association has recruited 40 hospitals to take part in the inaugural program. Teams in these facilities will have the opportunity to collaborate with other hospitals and with nationally recognized experts, access exclusive educational resources and share successful quality improvement models.

“We are committed to advancing science that transforms patient care, especially in areas like HFpEF and HFmrEF, where gaps in evidence and treatment persist,” said Robert Perkins, M.D., M.P.H., FACP, vice president of U.S. medical affairs cardiovascular and renal at Bayer. “We’re proud to support this American Heart Association initiative to help identify and scale effective care models that can improve outcomes for the millions of people living with these forms of heart failure.”

Visit heart.org/IMPLEMENTEF to stay informed about insights from the initiative and more. 

Additional Resources:

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.   

For Media Inquiries: 214-706-1173

Michelle Rosenfeld: michelle.rosenfeld@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

[1] Savarese G, Stolfo D, Sinagra G, Lund L. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol 19, 100–116 (2022). https://doi.org/10.1038/s41569-021-00605-5; Shah S, Kitzman D, et al. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap. Circulation. 2016. 134(1). https://doi.org/10.1161/CIRCULATIONAHA.116.02188; Shah, K, Xu, H, Matsouaka, R. et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. JACC. 2017 Nov, 70 (20) 2476–2486. https://doi.org/10.1016/j.jacc.2017.08.074.

[2] Savarese G, Stolfo D, Sinagra G, Lund L. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol 19, 100–116 (2022). https://doi.org/10.1038/s41569-021-00605-5; Chris J Kapelios, Bahira Shahim, Lars H Lund, Gianluigi Savarese, Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction. Cardiac Failure Review. 2023;9:e14. https://doi.org/10.15420/cfr.2023.03.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.